Chinese medicine composition used for treating non-active stage infiltrative exophthalmos of thyroid-associated ophthalmopathy and preparation method thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
An inactive, invasive technology, applied in the direction of drug combinations, pharmaceutical formulations, medical preparations containing active ingredients, etc., can solve problems such as lack of system integrity
Active Publication Date: 2009-09-16
LONGHUA HOSPITAL SHANGHAI UNIV OF TRADITIONAL CHINESE MEDICINE
View PDF0 Cites 7 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Although all have achieved certain curative effects, they have more one-sided limitations and lack of system integrity
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0025] Weigh 1000 grams of raw Astragalus membranaceus, 1000 grams of Salvia miltiorrhiza, 1000 grams of white mustard seed, 1500 grams of plantain seed, 1500 grams of Hedyotis diffusa, 900 grams of cassia twig, add 4 times the amount of water, decoct for 1.5 hours, filter, and concentrate To a clear paste with a relative density of about 1.35 (80°C), add an appropriate amount of dextrin, granulate (14-16 mesh), vacuum dry (80°C), and pack.
Embodiment 2
[0027] Weigh 1000 grams of raw Astragalus membranaceus, 2000 grams of Salvia miltiorrhiza, 1500 grams of white mustard seed, 2000 grams of plantain seed, 2000 grams of Hedyotis diffusa, 1200 grams of cassia twig, add 6 times the amount of 75% ethanol, and reflux extraction twice, each time After 1.5 hours, filter, combine the filtrates, recover ethanol until there is no alcohol smell, concentrate to a clear paste with a relative density of about 1.35 (80°C), add an appropriate amount of dextrin, granulate (14-16 mesh), and vacuum dry (80°C) , subpackage.
Embodiment 3
[0029] Weigh 1,000 grams of raw Astragalus membranaceus, 3,000 grams of Salvia miltiorrhiza, 1,500 grams of white mustard seed, 3,000 grams of plantain seed, 3,000 grams of Hedyotis diffusa, 1,500 grams of cassia twig, add 8 times the amount of 90% ethanol, and reflux three times for 1.5 hours each time , filter, combine the filtrates, recover ethanol until there is no alcohol smell, concentrate to a clear paste with a relative density of about 1.35 (80°C), add an appropriate amount of dextrin, granulate (14-16 mesh), vacuum dry (80°C), and separate Pack.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a Chinese medicine composition used for treating non-active stage infiltrative exophthalmos of thyroid-associated ophthalmopathy; the traditional Chinese medicine composition is prepared by the following bulk drugs by weight: 10 parts to 30 parts of raw astragalus root, 10 parts to 30 parts of salvia, 9 parts to 15 parts of white mustard Seed, 15 parts to 30 parts of asiatic plantain seed, 15 parts to 30 parts of hedyotis diffusa, and 9 parts to 15 parts of cassia twig. The clinical study in treating non-active stage infiltrative exophthalmos of thyroid-associated ophthalmopathy shows that the total effective rate of the Chinese medicine syndrome score curative effect of the Chinese medicine composition is 85.29 percent; and the Chinese medicine composition can effectively reduce the exophthalmos degree of the patients with non-active stage infiltrative exophthalmos of thyroid-associated ophthalmopathy, and the total effective rate is 76.47 percent. The invention also discloses a preparation method of traditional Chinese medicine composition granules.
Description
technical field [0001] The invention relates to a traditional Chinese medicine composition for treating thyroid-associated ophthalmopathy (infiltrating exophthalmos in inactive stage); the invention also relates to a preparation method of the traditional Chinese medicine composition. Background technique [0002] In recent years, due to environmental factors such as genetic factors, increased intake of iodized salt, tense pace of life, and increased work pressure, the incidence of thyroid-related ophthalmopathy has increased year by year. Therefore, among the orbital diseases of the adult group, thyroid-related ophthalmopathy ranks first at home and abroad. bit. [0003] Scholars at home and abroad have a long history of research on thyroid-related ophthalmopathy, but the progress is slow. In the past 20 years, with the rapid development of science and technology, the research process of thyroid-associated ophthalmopathy has been greatly promoted, and the close relationship...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/74A61P27/02A61P5/16
Inventor 李红徐蓉娟
Owner LONGHUA HOSPITAL SHANGHAI UNIV OF TRADITIONAL CHINESE MEDICINE
Login to view more 
Login to view more